| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Ocular Therapeutix, Inc.'s insiders have reduced their positions by a net 63,819 shares worth roughly $568K. In the past 30 days, 0 insiders bought and 3 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 3 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), OCUL's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 744.9K | - | - | |
| COO | 366.5K | $3.75M | - | |
| Other | 326.9K | $3.52M | - | |
| Other | 307.5K | $2.17M | -10,869 | |
| Other | 300.1K | $2.48M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Anderman Todd | Chief Legal Officer | Sell | 11,984 | $7.29 | $87,363.36 | -7.9% | |
| Oct 2, 2026 | Kaiser Peter | Chief Development Officer | Sell | 9,990 | $7.05 | $70,429.50 | -3.8% | |
| Oct 2, 2026 | Heier Jeffrey S.61 | Chief Scientific Officer | Sell | 10,869 | $7.05 | $76,626.45 | -3.4% | |
| Aug 31, 2026 | Notman Donald | Chief Operating Officer | Sell | 1,099 | $10.24 | $11,253.76 | -0.3% | |
| Aug 24, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,897 | $10.78 | $20,449.66 | -0.6% | |
| Aug 24, 2026 | Kaiser Peter | Chief Development Officer | Sell | 3,035 | $10.77 | $32,686.95 | -1.1% | |
| Aug 24, 2026 | Heier Jeffrey S.61 | Chief Scientific Officer | Sell | 3,296 | $10.78 | $35,530.88 | -1.0% | |
| Aug 24, 2026 | Dugel Pravin | See Remarks | Sell | 21,649 | $10.77 | $233,159.73 | -0.8% | |
| Jun 3, 2026 | Waheed Nadia | Chief Medical Officer | Sell | 14,828 | $8.27 | $122,627.56 | -4.7% | |
| May 26, 2026 | Nayak Sanjay | Chief Strategy Officer | Sell | 1,858 | $8.20 | $15,235.60 | -0.6% |